Roche NimbleGen introduces enhanced whole exome sequencing solution for medical and translational research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Roche NimbleGen introduced an enhanced whole exome sequencing solution for medical and translational research.

Roche announced the global launch of the SeqCap EZ MedExome Target Enrichment Kit, a comprehensive whole exome sequencing solution designed to increase the discovery and detection of human genetic variants associated with disease while reducing sequencing costs.

Pekka Ellonen, head of the sequencing unit for the Institute for Molecular Medicine Finland at the University of Helsinki, said, “We have evaluated a number of target enrichment systems for whole exome sequencing.

The kit is labeled “for research use only. It isn’t approved for diagnostic procedures.

Table of Contents

YOU MAY BE INTERESTED IN

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login